Neurocrine Biosciences rare disease drug possibly tied to safety issues, experts say

Prader-Willi syndrome experts raise safety concerns over Neurocrine's Vykat XR

Medical experts specializing in Prader-Willi syndrome flagged serious adverse events in patients taking Neurocrine Biosciences' drug Vykat XR, raising safety concerns about the treatment for the rare genetic disorder.